our Story

Our team was first assembled in 2005 to provide unbiased, scientifically-sound treatment options to patients with degenerative diseases. The organization arose from the unmet need to provide stem cell therapies that had been shown by others to meet the bar of safety in Phase I trials but were not yet widely available because efficacy had not yet been proven.

Our science originates from an American biotechnology company founded by Neil Riordan, PhD who, together with leading Universities has published numerous papers in peer-reviewed medical journals and has 17 families of patent applications.

Our medicine is founded on clinical use of stem cells. Since opening our doors in Panama City, Panama (2006), we have performed over 25,000 procedures. In order to incorporate the most recent advancements into patient care, we routinely interact with colleagues in the USA and internationally, many of whom are using stem cells in clinical trials.

The specially selected adult stem cells used to treat autism at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal).  Umbilical cords are donated by mothers after normal, healthy births. Because they are collected right after birth, umbilical cord-derived cells are much more potent than their “older” counterparts like bone marrow-derived cells for instance.  Before they are approved for treatment, all umbilical cord-derived stem cells are screened for viruses and bacteria to International Blood Bank Standards.

Golden Cells™ - the stem cell institute advantage

Through retrospective analysis of our cases, we have identified proteins and genes that allow us to screen several hundred umbilical cord donations to find the ones that we know are most effective – those that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration. We only use these cells, and we call them Golden Cells™.

Umbilical cord-derived Golden Cells™ are ideal for the treatment of autism because they allow our physicians to administer uniform doses and they do not require any stem cell collection from the patient, which for autistic children and their parents, can be an arduous process. 

Golden Cells™ pose no rejection risk because the body does not recognize them as foreign.

Our Mission

Our mission is to be at the forefront of research with novel treatment protocols for chronic diseases using adult stem cells, always according to the highest international bioethics standards, and offering, with transparency, honesty and human quality, treatments developed to improve the condition of our patients.

Neil takes readers on a riveting journey through the past, present, and future of stem cell therapy. His well-researched, educational, and entertaining book could change your life. I highly recommend it."

– Tony Robbins, NY Times #1 Bestselling Author